Insider · CIK 0001653967

Votruba Michal

Reports to the SEC for 3 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001653967

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-09	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2024-06-10	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2024-06-10	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−17K sh	—	—	0
2023-06-26	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−17K sh	—	—	0
2023-06-26	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2022-05-19	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−17K sh	—	—	0
2022-05-19	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2021-06-11	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−14.5K sh	—	—	0
2021-06-11	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2020-05-21	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-21	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−20K sh	—	—	0
2019-05-23	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,700 sh	—	—	4,700
2019-05-23	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	−4,700 sh	—	—	0
2019-03-07	BTAIBioXcel Therapeutics, Inc. · Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$7.91	−$79.1K	0
2018-10-08	EMMAEmmaus Life Sciences, Inc.A Award	Director	AAward	+144K sh	$1.38	+$199K	144,000
2018-10-08	EMMAEmmaus Life Sciences, Inc.A Award	Director	AAward	+144K sh	$1.38	+$199K	144,000
2018-10-08	EMMAEmmaus Life Sciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−144K sh	$1.38	−$199K	0
2016-04-05	EMMAEmmaus Life Sciences, Inc.A Award	Director	AAward	+250K sh	—	—	250,000
2015-08-20	EMMAEmmaus Life Sciences, Inc. · Option to PurchaseA Award	Director	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Jan 124
Votruba Michal0001104659-26-002978
SEC(opens sec.gov)
Jun 114
Votruba Michal0001104659-24-070518
SEC(opens sec.gov)
Jun 284
Votruba Michal0001104659-23-075863
SEC(opens sec.gov)
May 234
Votruba Michal0001104659-22-063971
SEC(opens sec.gov)
Jun 154
Votruba Michal0001104659-21-081588
SEC(opens sec.gov)
May 264
Votruba Michal0001104659-20-065871
SEC(opens sec.gov)
Jun 194
Votruba Michal0001104659-19-036496
SEC(opens sec.gov)
Mar 184
Votruba Michal0001104659-19-015669
SEC(opens sec.gov)
Nov 204/A
Votruba Michal0001615774-18-013077
SEC(opens sec.gov)
Oct 104
Votruba Michal0001615774-18-010703
SEC(opens sec.gov)
Apr 74
MYnd Analytics, Inc.0001615774-16-004868
SEC(opens sec.gov)
Sep 244
CNS RESPONSE, INC.0001615774-15-002696
SEC(opens sec.gov)

Companies

Address

C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR

NEW HAVEN, CT, 06511